5HLS image
Entry Detail
PDB ID:
5HLS
Keywords:
Title:
Crystal structure of the first bromodomain of human BRD4 bound to CPI-0610
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2016-01-15
Release Date:
2016-02-10
Method Details:
Experimental Method:
Resolution:
2.18 Å
R-Value Free:
0.27
R-Value Work:
0.18
R-Value Observed:
0.19
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Bromodomain-containing protein 4
Chain IDs:A
Chain Length:128
Number of Molecules:1
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials.
J.Med.Chem. 59 1330 1339 (2016)
PMID: 26815195 DOI: 10.1021/acs.jmedchem.5b01882

Abstact

In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB. Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clinical trials for hematological malignancies (CPI-0610).

Legend

Protein

Chemical

Disease

Primary Citation of related structures